Novel anti-inflammatory peptide alleviates liver ischemia-reperfusion injury

Abstract

Ischemia-reperfusion injury (IRI) remains an unavoidable challenge in liver surgery, with macrophages playing a critical role in its pathogenesis. However, the mechanisms by which macrophages regulate the pathogenesis of IRI are not well understood. Through a target-guided screening approach, we identified a small 3 kDa peptide (SjDX5-271) from various schistosome egg-derived peptides that induced M2 macrophage polarization. SjDX5-271 treatment protected mice against liver IRI by promoting M2 macrophage polarization, and this protective effect was abrogated when the macrophages were depleted. Transcriptomic sequencing showed that the TLR signaling pathway was significantly inhibited in macrophages from the SjDX5-271 treatment group. We further identified that SjDX5-271 promoted M2 macrophage polarization by inhibiting the TLR4/MyD88/NF-κB signaling pathway and alleviated hepatic inflammation in liver IRI. Collectively, SjDX5-271 exhibited some promising therapeutic effects in IRI and represented a novel therapeutic approach, potentially applicable to other immune-related diseases. The current study demonstrates the potential of new biologics from the parasite, enhances our understanding of host-parasite interplay, and provides a blueprint for future therapies for immune-related diseases.

Keywords

schistosome-derived peptide / liver ischemia-reperfusion injury / macrophage / toll-like receptor-4

Funding

This work was supported by the National Natural Science Foundation of China (Grant No. 81971965).

Acknowledgments

We thank Dr. Ziyi Wang (Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital) for providing technical assistance with the liver IRI model.

References

[1] Zhang H, Ni M, Wang H, et al. Gsk3β regulates the resolution of liver ischemia/reperfusion injury via MerTK[J]. JCI Insight, 2023, 8(1): e151819. doi: 10.1172/jci.insight.151819

[2] Jiménez-Castro MB, Cornide-Petronio ME, Gracia-Sancho J, et al. Inflammasome-mediated inflammation in liver ischemia-reperfusion injury[J]. Cells, 2019, 8(10): 1131. doi: 10.3390/cells8101131

[3] Wang H, Xi Z, Deng L, et al. Macrophage polarization and liver ischemia-reperfusion injury[J]. Int J Med Sci, 2021, 18(5): 1104-1113. doi: 10.7150/ijms.52691

[4] Nakata Y, Kono H, Akazawa Y, et al. Role of podoplanin and Kupffer cells in liver injury after ischemia-reperfusion in mice[J]. Surg Today, 2022, 52(2): 344-353. doi: 10.1007/s00595-021-02378-3

[5] Ye L, He S, Mao X, et al. Effect of hepatic macrophage polarization and apoptosis on liver ischemia and reperfusion injury during liver transplantation[J]. Front Immunol, 2020, 11: 1193. doi: 10.3389/fimmu.2020.01193

[6] Palma A, Jarrah AS, Tieri P, et al. Gene regulatory network modeling of macrophage differentiation corroborates the continuum hypothesis of polarization states[J]. Front Physiol, 2018, 9: 1659. doi: 10.3389/fphys.2018.01659

[7] Ding W, Duan Y, Qu Z, et al. Acidic microenvironment aggravates the severity of hepatic ischemia/reperfusion injury by modulating M1-polarization through regulating PPAR-γ signal[J]. Front Immunol, 2021, 12: 697362. doi: 10.3389/fimmu.2021.697362

[8] Wiedemann M, Voehringer D. Immunomodulation and immune escape strategies of gastrointestinal helminths and schistosomes[J]. Front Immunol, 2020, 11: 572865. doi: 10.3389/fimmu.2020.572865

[9] Tang H, Liang Y, Chen Z, et al. Soluble egg antigen activates M2 macrophages via the STAT6 and PI3K pathways, and Schistosoma japonicum alternatively activates macrophage polarization to improve the survival rate of septic mice[J]. J Cell Biochem, 2017, 118(12): 4230-4239. doi: 10.1002/jcb.26073

[10] Shen C, Zhu X, Xu X, et al. Identification and characterization of antigenic properties of Schistosoma japonicum heat shock protein 90α derived peptides[J]. Pathogens, 2022, 11(11): 1238. doi: 10.3390/pathogens11111238

[11] Ni Y, Xiong R, Zhu Y, et al. A target-based discovery from a parasitic helminth as a novel therapeutic approach for autoimmune diseases[J]. eBioMedicine, 2023, 95: 104751. doi: 10.1016/j.ebiom.2023.104751

[12] Yi Z, Deng M, Scott MJ, et al. Immune-responsive gene 1/itaconate activates nuclear factor erythroid 2-related factor 2 in hepatocytes to protect against liver ischemia-reperfusion injury[J]. Hepatology, 2020, 72(4): 1394-1411. doi: 10.1002/hep.31147

[13] Mao Y, Han CY, Hao L, et al. p21-activated kinase 4 inhibition protects against liver ischemia/reperfusion injury: Role of nuclear factor erythroid 2-related factor 2 phosphorylation[J]. Hepatology, 2022, 76(2): 345-356. doi: 10.1002/hep.32384

[14] Yoon SH, Kang HB, Kim J, et al. Diminazene aceturate attenuates hepatic ischemia/reperfusion injury in mice[J]. Sci Rep, 2022, 12(1): 18158. doi: 10.1038/s41598-022-21865-2

[15] Chang H, Ni Y, Shen C, et al. Peritoneal GATA6⁺ macrophage drives hepatic immunopathogenesis and maintains the T_reg cell niche in the liver[J]. Immunology, 2022, 167(1): 77-93. doi: 10.1111/imm.13519

[16] Sosa RA, Terry AQ, Kaldas FM, et al. Disulfide high-mobility group box 1 drives ischemia-reperfusion injury in human liver transplantation[J]. Hepatology, 2021, 73(3): 1158-1175. doi: 10.1002/hep.31324

[17] Jayant K, Reccia I, Shapiro AMJ. Normothermic ex-vivo liver perfusion: where do we stand and where to reach?[J]. Expert Rev Gastroenterol Hepatol, 2018, 12(10): 1045-1058. doi: 10.1080/17474124.2018.1505499

[18] Li S, Yi Z, Deng M, et al. TSLP protects against liver I/R injury via activation of the PI3K/Akt pathway[J]. JCI Insight, 2019, 4(22). doi: 10.1172/jci.insight.129013

[19] Xu X, Gao W, Li L, et al. Annexin A1 protects against cerebral ischemia-reperfusion injury by modulating microglia/macrophage polarization via FPR2/ALX-dependent AMPK-mTOR pathway[J]. J Neuroinflammation, 2021, 18(1): 119. doi: 10.1186/s12974-021-02174-3

[20] Dar WA, Sullivan E, Bynon JS, et al. Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms[J]. Liver Int, 2019, 39(5): 788-801. doi: 10.1111/liv.14091

[21] Ni M, Zhang J, Sosa R, et al. T-cell immunoglobulin and mucin domain-containing protein-4 is critical for kupffer cell homeostatic function in the activation and resolution of liver ischemia reperfusion injury[J]. Hepatology, 2021, 74(4): 2118-2132. doi: 10.1002/hep.31906

[22] Wang Z, Han S, Chen X, et al. Eva1a inhibits NLRP3 activation to reduce liver ischemia-reperfusion injury via inducing autophagy in kupffer cells[J]. Mol Immunol, 2021, 132: 82-92. doi: 10.1016/j.molimm.2021.01.028

[23] Yu Y, Wang J, Wang X, et al. Schistosome eggs stimulate reactive oxygen species production to enhance M2 macrophage differentiation and promote hepatic pathology in schistosomiasis[J]. PLoS Negl Trop Dis, 2021, 15(8): e0009696. doi: 10.1371/journal.pntd.0009696

[24] Ma Z, Sun X, Zheng W, et al. Schistosoma japonicum eggs exerts protective effects in an experimental ulcerative colitis model[J]. Biomed Environ Sci, 2022, 35(11): 1085-1089. doi: 10.3967/bes2022.138

[25] Gong W, Huang F, Sun L, et al. Toll-like receptor-2 regulates macrophage polarization induced by excretory-secretory antigens from Schistosoma japonicum eggs and promotes liver pathology in murine schistosomiasis[J]. PLoS Negl Trop Dis, 2018, 12(12): e0007000. doi: 10.1371/journal.pntd.0007000

[26] Yang M, Sunderland K, Mao C. Virus-derived peptides for clinical applications[J]. Chem Rev, 2017, 117(15): 10377-10402. doi: 10.1021/acs.chemrev.7b00100

[27] Robinson SD, Safavi-Hemami H. Venom peptides as pharmacological tools and therapeutics for diabetes[J]. Neuropharmacology, 2017, 127: 79-86. doi: 10.1016/j.neuropharm.2017.07.001

[28] Garcia DA, Baglin TP, Weitz JI, et al. Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines[J]. Chest, 2012, 141(S2): e24S-e43S. doi: 10.1378/chest.11-2291

[29] Xu X, Huang X, Zhang Y, et al. Self-regulated hirudin delivery for anticoagulant therapy[J]. Sci Adv, 2020, 6(41): eabc0382. doi: 10.1126/sciadv.abc0382

[30] Soares JB, Pimentel-Nunes P, Afonso L, et al. Increased hepatic expression of TLR2 and TLR4 in the hepatic inflammation-fibrosis-carcinoma sequence[J]. Innate Immun, 2012, 18(5): 700-708. doi: 10.1177/1753425912436762

[31] Zhang J, Li Q, Zou YR, et al. HMGB1-TLR4-IL-23-IL-17A axis accelerates renal ischemia-reperfusion injury via the recruitment and migration of neutrophils[J]. Int Immunopharmacol, 2021, 94: 107433. doi: 10.1016/j.intimp.2021.107433

[32] Jiang X, Kuang G, Gong X, et al. Glycyrrhetinic acid pretreatment attenuates liver ischemia/reperfusion injury via inhibiting TLR4 signaling cascade in mice[J]. Int Immunopharmacol, 2019, 76: 105870. doi: 10.1016/j.intimp.2019.105870

[33] Chang WJ, Toledo-Pereyra LH. Toll-like receptor signaling in liver ischemia and reperfusion[J]. J Invest Surg, 2012, 25(4): 271-277. doi: 10.3109/08941939.2012.687802

[34] Zhang J, Zheng Y, Luo Y, et al. Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2/TLR4/NF-κB pathways in BV2 cells[J]. Mol Immunol, 2019, 116: 29-37. doi: 10.1016/j.molimm.2019.09.020

[35] Huang J, Xie P, Dong Y, et al. Inhibition of Drp1 SUMOylation by ALR protects the liver from ischemia-reperfusion injury[J]. Cell Death Differ, 2021, 28(4): 1174-1192. doi: 10.1038/s41418-020-00641-7